Armando Martins - Profarma Distribuidora Director

PFRM3 Stock  BRL 5.79  0.19  3.39%   

Director

Mr. Armando Sereno Diogenes Martins has served as a Member of the Board of Directors of Profarma Distribuidora de Produtos Farmaceuticos SA since April 3, 2008. From 1989 to 1991, he was Financial Consultant at Accenture in the financial institutions sector. He was also Business Development Officer for Grupo Arbi. From 1994 to 1998, he was Senior Officer of Banco de Investimentos Garantia. He was Officer at Credit Suisse First Boston CSFB in Brazil for five years. He founded Singular Assessoria Financeira Ltda in 2003. He gained a degree from New York University and a Bachelor in Telecommunications Engineering from Instituto Militar de Engenharia . since 2008.
Age 42
Tenure 16 years
Phone55 21 4009 0200
Webhttps://www.profarma.com.br

Profarma Distribuidora Management Efficiency

The company has return on total asset (ROA) of 0.0368 % which means that it generated a profit of $0.0368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0645 %, meaning that it generated $0.0645 on every $100 dollars invested by stockholders. Profarma Distribuidora's management efficiency ratios could be used to measure how well Profarma Distribuidora manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 740.04 M in total debt with debt to equity ratio (D/E) of 91.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Profarma Distribuidora has a current ratio of 1.24, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Profarma Distribuidora until it has trouble settling it off, either with new capital or with free cash flow. So, Profarma Distribuidora's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Profarma Distribuidora sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Profarma to invest in growth at high rates of return. When we think about Profarma Distribuidora's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Alvaro SouzaBanco Santander SA
68
Esteves ColnagoCentrais Eltricas Brasileiras
N/A
Samuel HananCentrais Eltricas Brasileiras
67
Joao SallesIta Unibanco Holding
N/A
Henri PenchasIta Unibanco Holding
69
Ricardo MarinoIta Unibanco Holding
44
Amos GenishIta Unibanco Holding
57
Pricilla SantanaCentrais Eltricas Brasileiras
42
Irany AnnaBanco Do Estado
54
Jose CoimbraCentrais Eltricas Brasileiras
N/A
Manfred GartzCompanhia Brasileira De
N/A
Ricardo HingelBanco Do Estado
N/A
Deborah WrightBanco Santander SA
59
Marcio SchettiniIta Unibanco Holding
50
Joao LianCentrais Eltricas Brasileiras
52
Walter MalieniCentrais Eltricas Brasileiras
62
Viviane LalliBanco Santander SA
58
Walter OliveiraPetrleo Brasileiro SA
58
Jailson AlvesCentrais Eltricas Brasileiras
39
Milton MatsumotoBanco Bradesco SA
74
Viviane LalliBanco Santander SA
58
Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people. Profarma Distribuidora De (PFRM3) is traded on Sao Paulo Exchange in Brazil and employs 7,077 people.

Management Performance

Profarma Distribuidora Leadership Team

Elected by the shareholders, the Profarma Distribuidora's board of directors comprises two types of representatives: Profarma Distribuidora inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Profarma. The board's role is to monitor Profarma Distribuidora's management team and ensure that shareholders' interests are well served. Profarma Distribuidora's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Profarma Distribuidora's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sammy Birmarcker, CEO, Member of the Executive Board, Chairman of the Board
Armando Martins, Director
Fernando Perrone, Independent Director
Adriano Prado, Member Officers
Maximiliano Fischer, CFO, Director of Investor Relations, Member of the Executive Board
Dan Ioschpe, Independent Director
Manoel Birmarcker, Vice Chairman of the Board

Profarma Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Profarma Distribuidora a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Profarma Distribuidora using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora De. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Profarma Stock analysis

When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Please note, there is a significant difference between Profarma Distribuidora's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profarma Distribuidora is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profarma Distribuidora's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.